FIBROGEN INC — Director's Dealing 2022

Jun 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2022-06-16

Reporting Person: Lema Gerald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-16	Common Stock	A	15777	$0.00	Acquired	20477	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-16	Stock Option (Right to Buy)	$9.00	A	25684	Acquired	2032-06-15	Common Stock (25684)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	16600	Indirect

Footnotes

F1: Represents the grant of restricted stock units that vest on the earlier of June 16, 2023 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.

F2: Options vest on the earlier of June 16, 2023 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.